Inborn Errors of Metabolism Involving Complex Molecules Lysosomal and Peroxisomal Storage Diseases

被引:19
作者
Bellettato, Cinzia Maria [1 ]
Hubert, Leroy [2 ]
Scarpa, Maurizio [1 ,3 ,4 ]
Wangler, Michael F. [2 ,5 ,6 ]
机构
[1] Brains Brains Fdn, Dept Women & Children Hlth, Via Giustiniani 3, I-35128 Padua, Italy
[2] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[3] Helios Dr Horst Schmidt Klin, Ctr Rare Dis, Dept Pediat & Adolescent Med, Ludwig Erhard Str 100, D-65199 Wiesbaden, Germany
[4] Univ Padua, Dept Women & Children Hlth, Via Giustiniani 3, I-35128 Padua, Italy
[5] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA
[6] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA
关键词
Peroxisome; Lysosome; Storage disorder; Very long chain fatty acids; BIFUNCTIONAL PROTEIN-DEFICIENCY; X-LINKED ADRENOLEUKODYSTROPHY; ZELLWEGER SPECTRUM; BIOGENESIS DISORDERS; KRABBE DISEASE; FABRY-DISEASE; ACID THERAPY; MUTATIONS; BIOCHEMISTRY; PHENOTYPE;
D O I
10.1016/j.pcl.2017.11.011
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Peroxisomes and lysosomes are distinct subcellular compartments that underlie several pediatric metabolic disorders. Knowledge of their function and cell biology leads to understanding how the disorders result from genetic defects. Diagnostic and therapeutic approaches for the disorders take advantage of the cell biology mechanisms. Peroxisomal disorders are characterized by enzymatic defects in peroxisomal pathways leading to metabolic and lipid changes, whereas lysosomal storage disorders are marked by accumulation of substrates of lysosomal pathways inside the lysosome. The human diseases related to these two organelles are reviewed, focusing on general disease patterns and underlying diagnosis and treatment principles.
引用
收藏
页码:353 / +
页数:23
相关论文
共 66 条
[1]   A homozygousmutation in PEX16 identified by whole-exome sequencing ending a diagnostic odyssey [J].
Bacino, Carlos A. ;
Chao, Yu-Hsin ;
Seto, Elaine ;
Lotze, Tim ;
Xia, Fan ;
Jones, Richard O. ;
Moser, Ann ;
Wangler, Michael F. .
MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 5 :15-18
[2]   Lysosomal disorders: From storage to cellular damage [J].
Ballabio, Andrea ;
Gieselmann, Volkmar .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2009, 1793 (04) :684-696
[3]   Developing treatment options for metachromatic leukodystrophy [J].
Batzios, Spyros P. ;
Zafeiriou, Dimitrios I. .
MOLECULAR GENETICS AND METABOLISM, 2012, 105 (01) :56-63
[4]  
Baumgartner Matthias R, 2002, Semin Neonatol, V7, P85, DOI 10.1053/siny.2001.0089
[5]   Pathophysiology of neuropathic lysosomal storage disorders [J].
Bellettato, Cinzia Maria ;
Scarpa, Maurizio .
JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (04) :347-362
[6]   Cholic acid therapy in Zellweger spectrum disorders [J].
Berendse, Kevin ;
Klouwer, Femke C. C. ;
Koot, Bart G. P. ;
Kemper, Elles M. ;
Ferdinandusse, Sacha ;
Koelfat, Kiran V. K. ;
Lenicek, Martin ;
Schaap, Frank G. ;
Waterham, Hans R. ;
Vaz, Frederic M. ;
Engelen, Marc ;
Jansen, Peter L. M. ;
Wanders, Ronald J. A. ;
Poll-The, Bwee Tien .
JOURNAL OF INHERITED METABOLIC DISEASE, 2016, 39 (06) :859-868
[7]   'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature [J].
Biegstraaten, M. ;
van Schaik, I. N. ;
Aerts, J. M. F. G. ;
Hollak, C. E. M. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 (03) :337-349
[8]   Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines [J].
Braverman, Nancy E. ;
Raymond, Gerald V. ;
Rizzo, William B. ;
Moser, Ann B. ;
Wilkinson, Mark E. ;
Stone, Edwin M. ;
Steinberg, Steven J. ;
Wangler, Michael F. ;
Rush, Eric T. ;
Hacia, Joseph G. ;
Bose, Mousumi .
MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) :313-321
[9]   Functions of plasmalogen lipids in health and disease [J].
Braverman, Nancy E. ;
Moser, Ann B. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (09) :1442-1452
[10]   Clinical consequences of defects in peroxisomal β-oxidation [J].
Clayton, PT .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2001, 29 :298-305